ASX Share rice
Sun 09 May 2021 - 05:29:pm (Sydney)

OSX Share Price

OSTEOPORE LIMITEDOSXHealth Care Equipment & Services

OSX Company Information

Name:

Osteopore Limited

Sector:

Healthcare

Industry:

Medical Instruments & Supplies

Address:

No. 09-06 2 Tukang Innovation Grove Singapore Singapore 618305

Phone:

65 6250 2817

Chief Exec. Officer:

Mr. Khoon Seng Goh

Chief Financial Officer:

Dr. Carl Runde

Chief Technology Officer:

Dr. Jing Lim

Company Sec.:

Ms. Deborah Ho

Company Overview:

Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications. It specializes in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects; and Osteostrip. It operates in Singapore, Korea, Vietnam, and internationally. The company was founded in 2003 and is headquartered in Singapore.

OSX Share Price Information

Shares Issued:

117.27M

Market Capitalisation:

$59.22M

Revenue (TTM):

$1.50M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.0235

Profit Margin:

-1.2933

Operating Margin (TTM):

$-1.28

Return On Assets (TTM):

$-0.17

Return On Equity (TTM):

$-0.33

Quarterly Revenue Growth (YOY):

1.021

Gross Profit(TTM):

$0.96M

Diluted Earnings Per Share (TTM):

$-0.018

OSX CashFlow Statement

CashFlow Date:

2020-12-31

Investments:

$-381,044

Change To Liabilities:

$18.10K

Total Cashflow From Investing Activities:

$-381,044

Net Borrowings:

$-99,444

Net Income:

$-1,945,886

Total Cash From Operating Activities:

$-1,757,723

Depreciation:

$165.89K

Change To Inventory:

$-127,855

Change To Account Receivables:

$256.10K

Sale Purchase Of Stock:

$-563,386

Capital Expenditures:

$381.04K

OSX Income Statement

Income Date:

2020-12-31

Income Before Tax:

$-1,945,886

Net Income:

$-1,945,886

Gross Profit:

$1.68M

Operating Income:

$-1,928,284

Other Operating Expenses:

$-724,474

Interest Expense:

$17.60K

Total Revenue:

$2.23M

Cost Of Revenue:

$549.25K

OSX Balance Sheet

Balance Sheet Date:

2020-12-31

Total Liabilities:

$1.25M

Total Stockholder Equity:

$9M

Other Current Liabilities:

$14.06K

Total Assets:

$10.25M

Common Stock:

$26.07M

Other Current Assets:

$258.09K

Retained Earnings:

$-4,328,227

Cash:

$9.03M

Total Current Liabilities:

$1.25M

Short-Term Debt:

$427.36K

Property - Plant & Equipment:

$506.25K

Net Tangible Assets:

$9M

Total Current Assets:

$9.74M

Net Receivables:

$361.43K

Short-Term Investments:

$506.25K

Inventory:

$151.38K

Accounts Payable:

$325.67K

Short-Term Investments:

$506.25

Non Current Liabilities Total:

$0

OSX Share Price History

OSX News

08 Feb, 2021
Osteopore Limited (ASX: OSX) ("Osteopore" or the "Company"), a revenue-generating medical technology company that has commercialised a range of patented 3D printed bioresorbable products, is pleased to announce a Cooperation Agreement with Terumo Blood and Cell Technologies whereby both companies will collaborate to promote and sell their respective regenerative products throughout the Asia-Pacific region.
20 Jun, 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...